ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Carcinoma, Merkel Cell

Include trials that are no longer recruiting patients.

3 studies were found.
1.RecruitingOblimersen in Treating Patients With Metastatic or Recurrent Merkel Cell Carcinoma
Conditions: recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma; stage III Merkel cell carcinoma
2.RecruitingImatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
Conditions: stage III Merkel cell carcinoma; recurrent Merkel cell carcinoma; stage II Merkel cell carcinoma
3.RecruitingAntineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act